A safe, cost-effective, and high-throughput SARS-CoV-2 antigen capture ELISA suitable for large-scale screening in low-resource settings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A safe, cost-effective, and high-throughput SARS-CoV-2 antigen capture ELISA suitable for large-scale screening in low-resource settings

Published:2024-09 Issue: Volume:329 Page:114995
ISSN:0166-0934
Container-title:Journal of Virological Methods
language:en
Short-container-title:Journal of Virological Methods

Author:

Singh Ashutosh,Sahu Upasana,Kulkarni Pratik M.,Yadav Rupali,Bhatia Sandeep,Murugkar Harshad Vinayakrao,Hosamani Madhusudan,Basagoudanavar Suresh,Sharma Gaurav Kumar,Gupta Praveen Kumar,Kumar Naveen,Sanyal Aniket,Kumar Naveen

Funder

Indian Council of Agricultural Research

ICAR - National Agricultural Science Fund

Publisher

Elsevier BV

Reference29 articles.

1. Lateral flow test engineering and lessons learned from COVID-19;Budd;Nat. Rev. Bioeng.,2023

2. RT-qPCR Testing of SARS-CoV-2: A Primer;Bustin;Int. J. Mol. Sci.,2020

3. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies;Cao;Nature,2022

4. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization;Cele;Nature,2022

5. SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis;Deeks;BMJ,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP